EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO)
PHAR
Cash DividendsPositive News
EIPICO Declares EGP 2 Per Share Dividend Amid Robust Profit Surge
EIPICO announces EGP 2 per share dividend with 28% profit growth in 2023, signaling strong financial health and shareholder returns.
April 8, 2024 at 10:32:00 AMScore: 88

Cairo-based pharmaceutical giant EIPICO has announced a cash dividend of EGP 2 per share, set for distribution in two equal installments on April 30 and August 29, 2024. The company reported a 28% year-on-year jump in 2023 consolidated net profits to EGP 823.3 million, with revenues soaring to EGP 5.23 billion from EGP 3.95 billion in 2022. Non-consolidated profits also surged 24% to EGP 730.08 million, reflecting strong operational performance.
Recommended Actions
- Monitor EIPICO stock price near dividend payment dates
- Consider dividend reinvestment if holding long-term
- Compare current P/E ratio with industry peers
- Check institutional investor activity in recent filings
- Review cash flow statements for dividend sustainability
Positive Aspects
- 28% YoY profit increase
- 32% revenue growth
- Consistent dividend distribution
- Strong consolidated financial performance
Negative Aspects
- Dividend payout may temporarily reduce retained earnings
- Future performance dependent on maintaining growth momentum